|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 482.18 USD | +0.56% |
|
+1.62% | +36.55% |
| 12-08 | United Therapeutics Insider Sold Shares Worth $3,870,056, According to a Recent SEC Filing | MT |
| 12-05 | United Therapeutics Insider Sold Shares Worth $3,821,130, According to a Recent SEC Filing | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | US$518.25 | +8.08% | 12 | ||||||
| US$1,063.89 | +6.65% | 27 | ||||||
| US$203.42 | +0.89% | 24 | ||||||
| US$243.55 | +9.16% | 29 | ||||||
| CHF 318.45 | +0.24% | 18 | ||||||
| GBX 198.54 | +9.84% | 19 | ||||||
| CHF 133.55 | +1.2% | 19 | ||||||
| US$106.62 | +7.77% | 26 | ||||||
| DKK 390.79 | +30.7% | 20 | ||||||
| US$324.25 | +0.94% | 27 | ||||||
| US$130.63 | +7.79% | 25 | ||||||
| US$29.04 | +12.69% | 24 | ||||||
| €105.67 | +26.4% | 22 | ||||||
| US$487.28 | +10.23% | 25 | ||||||
| US$53.41 | +3.37% | 22 | ||||||
| GBX 18.47 | +1.45% | 18 | ||||||
| JP¥8,553.57 | +4.01% | 14 | ||||||
| US$492.17 | +14.45% | 24 | ||||||
| CN¥81.04 | +29.74% | 18 | ||||||
| Average | 708.03 | +9.77% | 22 | ||||||
| Weighted average by Cap. | 565.98 | +7.68% | 24 |
- Stock Market
- Equities
- UTHR Stock
- Sector United Therapeutics Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition